References
  1. Jones ME, Draghi DC, Brown NP, et al. Baseline surveillance profile of doripenem (DOR) against key gram-negative pathogens encountered in the United States. Presented at the 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 2006: San Francisco, CA.